SialylTn-mAb17-1A carbohydrate-protein conjugate vaccine: Effect of coupling density and presentation of SialylTn

Bioconjugate Chemistry

Volumn 16, Issue 6, 2005, Pages 1519-1528

  Kircheis, Ralf ^a   Vondru, Petra ^a   Nechansky, Andreas ^a   Ohler, Renate ^a   Loibner, Hans ^a   Himmler, Gottfried ^a   Mudde, Geert C ^a  

^a Igeneon AG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CYTOLOGY; EPITOPES; IMMUNE SYSTEM; T-CELLS; TUMORS; VACCINES;

ALHYDROGEL; CARBOHYDRATE EPITOPES; CARRIER MOLECULES; CELL SURFACES; CONJUGATE VACCINE; EXPRESSION PATTERNS; GLYCOSYLATIONS; IMMUNE RESPONSE; PROTEIN CONJUGATES; TUMOUR CELLS;

CARBOHYDRATES;

ALUMINUM HYDROXIDE; CANCER VACCINE; CARBOHYDRATE ANTIGEN; EDRECOLOMAB; IGN 402; IMMUNOGLOBULIN G; MONOMER; MUCIN; OVINE SUBMAXILLARY MUCIN; POLYETHYLENEIMINE; QS 21; SIALIC ACID DERIVATIVE; TUMOR CELL VACCINE; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CANCER; CANCER IMMUNOTHERAPY; DENSITY; DRUG CONJUGATION; DRUG FORMULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; MEMORY CELL; NONHUMAN; RABBIT; RHESUS MONKEY; T LYMPHOCYTE;

ANIMALIA; MACACA MULATTA; ORYCTOLAGUS CUNICULUS; OVIS;

EID: 27944483737     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc050157m     Document Type: Article

References (26)

1. Fung, P. Y. S., Madej, M., Koganty, R. R., and Longenecker, B. M. (1990) Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res. 50, 4308-4314.
2. Singhal, A., Fohn, M., and Hakomori, S-I. (1991) Induction of a α-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice. Cancer Res. 51, 1406-1411.
3. Zhang, S., Walberg, L. A., Helling, F., Ragupathi, G., Adluri, S., Lloyd, K. O., and Livingston P. O. (1996) Augmenting the immunogenicity of synthetic MUC-1 vaccines in mice. Cancer Res. 55, 3364-3368.
4. Zhang, H., Zhang, S., Cheung, N. K., Ragupathi, G., and Livingston, P. O. (1998) Antibodies can eradicate cancer micrometastases. Cancer Res. 58, 2844-2849.
5. Livingston, P. O., Wong, G. Y. C., Adluri, S., Tao, Y., Padavan, M., Parente, R., Hanlon, C., Helling, F., Ritter, G., Oettgen, H. F., and Old, L. J. (1994) Improved survival in AJCC stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J. Clin. Oncol. 12, 1036-1044.
6. MacLean, G. D., Reddish, M. A., Koganty, R. R., and Longenecker, B. M. (1996) Antibodies against mucin-associated SialylTn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine. J. Immunother. 19, 59-68.
7. Itzkowitz, S. H., Yuan, M., Montgomery, C. K., Kjeldsen, T., Takahashi, H. K., Bigbee, W. L., and Kim, Y. S. (1989) Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 49, 197-204.
8. Zhang, S., Zhang, S. H., Cordon-Cardo, C., Reuter, V. E., Singgal, A. K., Lloyd, K. O., and Livingston, P. O. (1997) Selection of tumor antigens as targets for immune attack using immunohistochemistry. II. Blood group-related antigens. Int. J. Cancer. 73, 50-56.
9. Zhang, S., Walberg, L. A., Ogata, S., Itzkowitz, S. H., Koganty, R. R., Reddish, M., Gandhi, S. S., Longenecker, B. M., Lloyd, K. O., and Livingston, P. O. (1995) Immune sera and monoclonal antibodies define two configurations for the sialylTn tumor antigen. Cancer Res. 55, 3364-3368.
10. Itzkowitz, S. H., Bloom, E. J., Kokal, W. A., Modin, G., Hakomori, S., and Kim, Y. S. (1990) Sialosyl-Tn: a novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66, 1960-1966.
11. Werther, J. L., Rivera-MacMurray, S., Bruckner, H., Tatematsu, M., and Itzkowitz, S. H. (1994) Mucin-associated sialosyl-Tn antigen expression in gastric cancer correlates with an adverse outcome. Br. J. Cancer 69, 613-616.
12. Nakada, H., Numata, Y., Inoue, M., Tanaka, N., Kitagawa, H., Funakoshi, I., Fukui, S., and Yamashina, I. (1991) Elucidation of an essential structure recognized by an anti-GalNAca-Ser(Thr) monoclonal antibody (MLS 128). J. Biol. Chem. 266, 12402-12405.
13. Tanaka, N., Nakada, H., Inoue, M., and Yamashina, I. (1999) Binding characteristics of an anti-Siaα2-6GalNAcα-Ser/Thr (sialylTn) monoclonal antibody (MLS132). Eur. J. Biochem. 263, 27-32.
14. Ragupathi, G., Howard, L., Capello, S., Koganthy, R. R., Qiu, D., Longenecker, B. M., Reddish, M. A., Lloyd, K. O., and Livingston, P. O. (1999) Vaccines prepared with SialylTn and SialylTn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and SialylTn-positive tumor cells. Cancer Immunol. Immunother. 48, 1-8.
15. Kagan, E., Ragupathi, G., Yi, S. S., Reis, C. A., Gildersleeve, J., Kahne, D., Clausen, H., Danishefsky, S. J., and Livingston, P. O. (2005) Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn. Cancer Immunol Immunother. 54, 424-430.
16. Lo-Man, R., Vichier-Guerre, S., Bay, S., Deriaud, E., Cantacuzene, D., and Leclerc, C. (2001) Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope. J. Immunol. 166, 2849-2854.
17. Lo-Man, R., Vichier-Guerre, S., Perraut, R., Deriaud, E., Huteau, V., BenMohamed, L., Diop, O. M., Livingston, P. O., Bay, S., and Leclerc, C. (2004) A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res. 64, 4987-4994.
18. Ragupathi, G., Coltart, D. M., Williams, L. J., Koide, F., Kagan, E., Allen, J., Harris, C., Glunz, P. W., Livingston, P. O., and Danishefsky, S. J. (2002) On the power of chemical synthesis: Immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines. Proc. Natl. Acad. Sci U.S.A. 99, 13699-13704.
19. Riethmuller, G., Schneider-Gadicke, E., Schlimok, G., Schmiegel, W., Raab, R., Hoffken, K., Gruber, R., Pichlmaier, H., Hirsche, H., and Pichlmayr, R. et al. (1994) Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study group. Lancet 343, 1172-1174.
20. Fagerberg, J., Ragnhammar, P., Liljefors, M., Hjelm, A. L., Mellstedt, H., and Frodin, J. E. (1996) Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A. Cancer Immunol. Immunother. 42, 81-87.
21. Fagerberg, J., Frodin, J. E., Wigzell, H., and Mellstedt, H. (1993) Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (abl). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy? Cancer Immunol. Immunother. 37, 264-270.
22. Settaf, A., Salzberg, M., Groiss, F., Eller, N., Schuster, M., Himmler, G., Kundi, M., Eckert, H., and Loibner, H. (2004) A randomized placebo-controlled Phase II study with the cancer vaccine IGN101 in patients with epithelial cancers. Presented at the iSBTc 19th Annual Meeting, San Franscisco, Nov 4-7.
23. Kircheis, R., Vondru, P., Zinöcker, I., Häring, D., Nechansky, A., Loibner, H., Himmler, G., and Mudde, G. C. Immunization of Rhesus monkeys with the conjugate vaccine IGN402 induces an IgG immune response against carbohydrate and protein antigens, and cancer cells. Vaccine, submitted
24. Ragupathi, G., Koide, F., Santhyan, N., Kagan, E., Spassova, M., Bornmann, W., Gregor, P., Reis, C. A., Clausen, H., Danishefsky, S. J., and Livingston, P. O. (2003) A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancer. Cancer Immunol Immunother. 52, 608-616.
25. Janin, J., and Wodak, S. (1997) Conformation of amino acid side-chains in proteins. J. Mol. Biol. 125, 357-386.
26. Harris, L. J., Larson, S. B., Hasel, K. W., and McPherson, A. (1997) Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36, 1581-1597.